$MIRM

$90.40▲ +5.3% YTD

6 SEC 13D/G filings tracked · Last updated Oct 12, 2026

Filing History

MIRM ▲ +5.3% - Mirum Pharmaceuticals, Inc.

CP $90.40▲ +5.3%Oct 12, 2026 · ThinkSabio Blog

$MIRM Mirum Pharmaceuticals: Phase 3 EXPAND Trial of LIVMARLI Meets Primary Endpoint; Shares Rise 6.1% Premarket ? • LIVMARLI significantly improved c…

News

MIRM ▲ +8.7% - Mirum Pharmaceuticals, Inc.

CP $93.40▲ +8.7%Oct 12, 2026 · ThinkSabio Blog

$MIRM Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases…

News

MIRM ▲ +5.1% - Mirum Pharmaceuticals, Inc.

CP $94.25▲ +5.1%Sep 28, 2026 · ThinkSabio Blog

$MIRM Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus…

News

MIRM ▲ +2.2% - Mirum Pharmaceuticals, Inc.

CP $91.30▲ +2.2%Sep 27, 2026 · ThinkSabio Blog

$MIRM Mirum Pharmaceuticals: Phase 3 AZURE-1 Topline Results for Brelovitug Due Sept. 28 ? • Investor call scheduled for 8:30 a.m. ET to present Phase…

SEC 13D/G

MIRM - Mirum Pharmaceuticals, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified

$99.05▲ 27.00%Aug 13, 2026 · ThinkSabio Blog

$MIRM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MIRM Mirum Pharmaceuticals, Inc. : $99.05 Sector: Healthcare |…

SEC 13D/G

MIRM - Mirum Pharmaceuticals, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$94.96▲ 21.76%Aug 6, 2026 · ThinkSabio Blog

$MIRM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MIRM Mirum Pharmaceuticals, Inc. : $94.96 Sector: Healthcare |…